Evaluación de un programa de intervención farmacéutica en pacientes con medicamentos de riesgo renal

The results of the study indicate that the application of a pharmaceutical care model based on the prospective validation of drugs with renal risk, very significantly improved the adaptation of dosing regimens in kidney disease.